JCI - Citations to Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected

Citations to this article

Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected

Douglas Marvel, Dmitry I. Gabrilovich

Douglas Marvel, Dmitry I. Gabrilovich

Published July 13, 2015
Citation Information: J Clin Invest. 2015;125(9):3356-3364. https://doi.org/10.1172/JCI80005.

View: Text | PDF

Total citations by year

Year:	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2009	Total
Citations:	19	34	51	65	80	77	62	71	79	63	7	1	609

Citation information

Citations to this article in year 2023 (51)

Title and authors	Publication	Year
Advancements in nanoparticle-based treatment approaches for skin cancer therapy Zeng L, Gowda BH, Ahmed MG, Abourehab MA, Chen ZS, Zhang C, Li J, Kesharwani P	Molecular Cancer	2023
Distinct phenotype of neutrophil, monocyte, and eosinophil populations indicates altered myelopoiesis in a subset of patients with multiple myeloma Ong KL, Davis MD, Purnell KK, Cutshall H, Pal HC, Connelly AN, Fay CX, Kuznetsova V, Brown EE, Hel Z	Frontiers in Oncology	2023
Myeloid-derived suppressor cells are associated with impaired Th1 and Th17 responses and severe pulmonary paracoccidioidomycosis which is reversed by anti-Gr1 therapy Preite NW, Kaminski VD, Borges BM, Calich VL, Loures FV	Frontiers in immunology	2023
Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells Jin K, Qian C, Lin J, Liu B	Frontiers in Oncology	2023
Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment Tian H, Cao J, Li B, Nice EC, Mao H, Zhang Y, Huang C	Bone Research	2023
Functional characterization of TSPAN7 as a novel indicator for immunotherapy in glioma. Chen L, Liu H, Li Y, Lin X, Xia S, Wanggou S, Li X	Frontiers in immunology	2023
Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy Tomela K, Pietrzak B, Galus Ł, Mackiewicz J, Schmidt M, Mackiewicz AA, Kaczmarek M	Cells	2023
Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment Ruan R, Li L, Li X, Huang C, Zhang Z, Zhong H, Zeng S, Shi Q, Xia Y, Zeng Q, Wen Q, Chen J, Dai X, Xiong J, Xiang X, Lei W, Deng J	Molecular Cancer	2023
Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies. Wang S, Zhao X, Wu S, Cui D, Xu Z	Biomarker Research	2023
Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target Feyza Gul Ozbay Kurt1,2,3,4, Samantha Lasser1,2,3,4, Ihor Arkhypov1,2,3,4, Jochen Utikal1,2,3†and Viktor Umansky1,2,3,4†*	Journal of Clinical Investigation	2023
An emerging role of inflammasomes in spinal cord injury and spinal cord tumor. Chen J, Shen Y, Shao X, Wu W	Frontiers in immunology	2023
Cellular Senescence, a Novel Area of Investigation for Metastatic Diseases. Faggioli F, Velarde MC, Wiley CD	Cells	2023
Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond Zhao Y, Du J, Shen X	Frontiers in immunology	2023
High anti-tumor activity of a novel alpha-fetoprotein-maytansinoid conjugate targeting alpha-fetoprotein receptors in colorectal cancer xenograft model. Griffin P, Hill WA, Rossi F, Boohaker R, Stinson K, Sherman I	Cancer Cell International	2023
Mobilization of monocytic myeloid-derived suppressor cells is regulated by PTH1R activation in bone marrow stromal cells Lee EJ, Lee KJ, Jung S, Park KH, Park SI	Bone Research	2023
Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cells. Qin G, Liu S, Liu J, Hu H, Yang L, Zhao Q, Li C, Zhang B, Zhang Y	Signal Transduction and Targeted Therapy	2023
Association between Fluoxetine Use and Overall Survival among Patients with Cancer Treated with PD-1/L1 Immunotherapy Magagnoli J, Narendran S, Pereira F, Cummings TH, Hardin JW, Sutton SS, Ambati J	Pharmaceuticals	2023
The Role of TLR4 in the Immunotherapy of Hepatocellular Carcinoma: Can We Teach an Old Dog New Tricks? Papadakos SP, Arvanitakis K, Stergiou IE, Lekakis V, Davakis S, Christodoulou MI, Germanidis G, Theocharis S	Cancers	2023
Siglec15 is a prognostic indicator and a potential tumor-related macrophage regulator that is involved in the suppressive immunomicroenvironment in gliomas Wang J, Xu L, Ding Q, Li X, Wang K, Xu S, Liu B	Frontiers in immunology	2023
Gasdermin D Plays an Oncogenic Role in Glioma and Correlates to an Immunosuppressive Microenvironment Li M, Jiang P, Wei S, Yang Y, Xiong L, Wang J, Li C	Biomolecules	2023
Monocytic MDSCs exhibit superior immune suppression via adenosine and depletion of adenosine improves efficacy of immunotherapy Sarkar OS, Donninger H, Al Rayyan N, Chew LC, Stamp B, Zhang X, Whitt A, Li C, Hall M, Mitchell RA, Zippelius A, Eaton J, Chesney JA, Yaddanapudi K	Science Advances	2023
Alterations in the Mammary Gland and Tumor Microenvironment of Formerly Obese Mice Kuziel G, Moore BN, Haugstad GP, Xiong Y, Williams AE, Arendt LM		2023
Pretreatment lymphocyte-to-monocyte ratio as a prognostic factor and influence on dose-effect in fractionated stereotactic radiotherapy for oligometastatic brain metastases in non-small cell lung cancer patients. Chen T, Tang M, Zhou Y, Wang Z, Li S, Wang H, Lu Y, Wang J, Shen W	Frontiers in Oncology	2023
Myeloid-Derived Suppressor Cells (MDSCs) in Ovarian Cancer—Looking Back and Forward Okła K	Cells	2023
Optimized CAR-T therapy based on spatiotemporal changes and chemotactic mechanisms of MDSCs induced by hypofractionated radiotherapy Zhang B, Hu M, Ma Q, Li K, Li X, He X, Shu P, Chen Y, Gao G, Qin D, Guo F, Zhao J, Liu N, Zhou K, Feng M, Liao W, Li D, Wang X, Wang Y	Molecular Therapy	2023
The recent progress of myeloid‐derived suppressor cell and its targeted therapies in cancers Ren R, Xiong C, Ma R, Wang Y, Yue T, Yu J, Shao B		2023
Systemic administration of STING agonist promotes myeloid cells maturation and antitumor immunity through regulating hematopoietic stem and progenitor cell fate. Xu T, Dai J, Tang L, Sun L, Si L, Guo J	Cancer Immunology, Immunotherapy	2023
Monocyte subsets associated with the efficacy of anti‑PD‑1 antibody monotherapy Ohkuma R, Fujimoto Y, Ieguchi K, Onishi N, Watanabe M, Takayanagi D, Goshima T, Horiike A, Hamada K, Ariizumi H, Hirasawa Y, Ishiguro T, Suzuki R, Iriguchi N, Tsurui T, Sasaki Y, Homma M, Yamochi T, Yoshimura K, Tsuji M, Kiuchi Y, Kobayashi S, Tsunoda T, Wada S	Oncology Letters	2023
CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting exhausted CD8+ T cells and immunosuppressive myeloid cells. Zhang Y, Hu J, Ji K, Jiang S, Dong Y, Sun L, Wang J, Hu G, Chen D, Chen K, Tao Z	Cell reports. Medicine	2023
Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics. Jin HR, Wang J, Wang ZJ, Xi MJ, Xia BH, Deng K, Yang JL	Journal of Hematology & Oncology	2023
Cancer Stem Cells and the Tumor Microenvironment in Tumor Drug Resistance. Gao Q, Zhan Y, Sun L, Zhu W	Stem Cell Reviews and Reports	2023
Role of the tumor microenvironment in the lymphatic metastasis of cervical cancer (Review) Wang L, Yi S, Teng Y, Li W, Cai J	Experimental and therapeutic medicine	2023
Fibroblast-derived PI16 sustains inflammatory pain via regulation of CD206+ myeloid cells Garrity R, Arora N, Haque MA, Weis D, Trinh RT, Neerukonda SV, Kumari S, Cortez I, Ubogu EE, Mahalingam R, Tavares-Ferreira D, Price TJ, Kavelaars A, Heijnen CJ, Shepherd AJ	Brain, Behavior, and Immunity	2023
Sending a Message: Use of mRNA Vaccines to Target the Tumor Immune Microenvironment Ramirez F, Zambrano A, Hennis R, Holland N, Lakshmanaswamy R, Chacon J	Human vaccines	2023
Progresses in biomarkers for cancer immunotherapy Lin X, Zong C, Zhang Z, Fang W, Xu P		2023
Galectin-1 mediates chronic STING activation in tumors to promote metastasis through MDSC recruitment Nambiar DK, Viswanathan V, Cao H, Zhang W, Guan L, Chamoli M, Holmes B, Kong C, Hildebrand R, Koong AJ, von Eyben R, Plevritis S, Li L, Giaccia A, Engleman E, Le QT	Cancer research	2023
Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis Nirala BK, Yamamichi T, Petrescu DI, Shafin TN, Yustein JT	Cancers	2023
Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy Sauerer T, Velázquez GF, Schmid C	Molecular Cancer	2023
Small molecule inhibitors for cancer immunotherapy and associated biomarkers – the current status Schlicher L, Green LG, Romagnani A, Renner F	Frontiers in immunology	2023
Targeting Myeloid-Derived Suppressor Cell Trafficking as a Novel Immunotherapeutic Approach in Microsatellite Stable Colorectal Cancer Johnson B	Cancers	2023
Understanding immune checkpoints and PD-1/PD-L1-mediated immune resistance towards tumour immunotherapy Singh S, Singh N, Baranwal M, Sharma S, Devi SS, Kumar S	3 Biotech	2023
Alterations in the mammary gland and tumor microenvironment of formerly obese mice. Kuziel G, Moore BN, Haugstad GP, Xiong Y, Williams AE, Arendt LM	BMC Cancer	2023
Integrating bulk and single-cell RNA sequencing data reveals epithelial-mesenchymal transition molecular subtype and signature to predict prognosis, immunotherapy efficacy, and drug candidates in low-grade gliomas. Wang C, He Z	Frontiers in pharmacology	2023
Targeting the myeloid microenvironment in neuroblastoma. Stip MC, Teeuwen L, Dierselhuis MP, Leusen JHW, Krijgsman D	Journal of experimental & clinical cancer research : CR	2023
Biofilms in Periprosthetic Orthopedic Infections Seen through the Eyes of Neutrophils: How Can We Help Neutrophils? Arciola CR, Ravaioli S, Mirzaei R, Dolzani P, Montanaro L, Daglia M, Campoccia D	International journal of molecular sciences	2023
A novel telomere-related genes model for predicting prognosis and treatment responsiveness in diffuse large B-cell lymphoma. Zhao Z, Shen X, Zhao S, Wang J, Tian Y, Wang X, Tang B	Aging	2023
Development of the RF-GSEA Method for Identifying Disulfidptosis-Related Genes and Application in Hepatocellular Carcinoma Ni L, Yu Q, You R, Chen C, Peng B	Current issues in molecular biology	2023
RNA m(6)A methylation and MDSCs: Roles and therapeutic implications for radiotherapy. Wang L, Katipally RR, Liang HL, Yang K, Pitroda SP, He C, Weichselbaum RR		2023
Myeloid cells in the era of cancer immunotherapy: Top 3 unanswered questions. Chaib M, Tanveer UA, Makowski L	Pharmacology & Therapeutics	2023
Isolation and immunosuppressive functions of myeloid-derived suppressor cell-derived exosomes. Parvin M, Rashid MH, Arbab AS	Methods in cell biology	2023
Considerations and approaches for cancer immunotherapy in the aging host Ontiveros CO, Murray CE, Crossland G, Curiel TJ	Cancer immunology research	2023

Advertisement